As YAP1 loss is proposed to be an early event in breast cancer [25], YAP1 downregulation in cell lines such as MCF-7 might have to be assessed at much later time points in order to better correlate findings between primary tumour data and cell lines. This evidence concerns the gene YAP1 and breast cancer.